SEARCH

SEARCH BY CITATION

References

  • Aukrust, P., Froland, S.S., Liabakk, N.B., Muller, F., Nordoy, I., Haug, C. & Espevik, T. (1994) Release of cytokines, soluble cytokine receptors, and interleukin-1 receptor antagonist after intravenous immunoglobulin administration in vivo. Blood, 84, 21362143.
  • Bredius, R.G.M., Derkx, B.H.F., Fijen, C.A.P., De Wit, T.P.M., De Haas, M., Weening, R.S., Van de Winkel, J.G.J. & Out, T.A. (1994) Fcγ receptor IIa (CD32) polymorphism in fulminant meningococcal septic shock in children. Journal of Infectious Diseases, 170, 848853.
  • Bussel, J.B. (2000) Fc receptor blockade and immune thrombocytopenic purpura. Seminars in Hematology, 37, 261266.
  • Bussel, J., Pham, L.C., Aledort, L. & Nachman, R. (1988) Maintenance treatment of adults with chronic refractory immune thrombocytopenic purpura using repeated intravenous infusions of gammaglobulin. Blood, 72, 121127.
  • Bussel, J.B., Kimberly, R., Clarkson, S., Nachman, R., Valinsky, J. & Unkeless, J.C. (1990) Infusion of a monoclonal anti-FcR III in patients with refractory ITP. Neo-Adjuvant Chemotherapy, 169, 883890.
  • Bussel, J.B., Graziano, J.N., Kimberly, R.P., Pahwa, S. & Aledort, L.M. (1991) Intravenous anti-D treatment of immune thrombocytopenic purpura: analysis of efficacy, toxicity, and mechanism of effect. Blood, 77, 18841893.
  • Bussel, J.B., Kaufmann, C.P., Ware, R.E. & Woloski, B.M. (2001) Do the acute platelet responses of patients with immune thrombocytopenic purpura (ITP) to IV anti-D and to IV gammaglobulin predict response to subsequent splenectomy? American Journal of Hematology, 67, 2733.
  • Cardo, L.J., Strack, M. & Williams, J. (1991) Anti-D for the treatment of splenectomized patients with immune thrombocytopenic purpura. Blood, 78, 27862787.
  • Coopamah, M.D., Freedman, J. & Semple, J.W. (2003) Anti-D initially stimulates an Fc-dependent leukocyte oxidative burst and subsequently suppresses erythrophagocytosis via interleukin-1 receptor antagonist. Blood, 102, 28622867.
  • Cooper, N., Woloski, B.M., Fodero, E.M., Novoa, M., Leber, M., Beer, J.H. & Bussel, J.B. (2002) Does treatment with intermittent infusions of intravenous anti-D allow a proportion of adults with recently diagnosed immune thrombocytopenic purpura to avoid splenectomy? Blood, 99, 19221927.
  • Farber, C.M., Crusiaux, A., Schandene, L., van Vooren, J.P., Goldman, M., Dupont, E. & Tasiaux, N. (1994) Tumor necrosis factor and intravenous gammaglobulins in common variable immunodeficiency. Clinical Immunology Immunopathology, 72, 233236.
  • Fehr, J., Hofmann, V. & Kappeler, U. (1982) Transient reversal of thrombocytopenia in idiopathic thrombocytopenic purpura by high-dose intravenous gamma globulin. New England Journal of Medicine, 306, 12541258.
  • Fleit, H.B., Kobasiuk, C.D., Daly, C., Furie, R., Levy, P.C. & Webster, O. (1992) A soluble form of FcγRIII is present in human serum and other body fluids and is elevated at sites of inflammation. Blood, 79, 27212728.
  • Hansen, R.J. & Balthasar, J.P. (2002) Effects of intravenous immunoglobulin on platelet count and antiplatelet antibody disposition in a rat model of immune thrombocytopenia. Blood, 100, 20872093.
  • Imbach, P., Barandun, S., D'Apuzzo, V., Baumgartner, C., Hirt, A., Morell, A., Rossi, E., Schoni, M., Vest, M. & Wagner, H.P. (1981) High-dose intravenous gammaglobulin for idiopathic thrombocytopenic purpura in childhood. Lancet, 6, 12281231.
  • Kimberly, R.P., Salmon, J.E., Bussel, J.B., Crow, M.K. & Hilgartner, M.W. (1984) Modulation of mononuclear phagocyte function by intravenous gamma-globulin. Journal of Immunology, 132, 745750.
  • Koene, H.R., Kleijer, M., Swaak, A.J., Sullivan, K.E., Bijl, M., Petri, M.A., Kallenberg, C.G., Roos, D., dem Borne, A.E. & de Haas, M. (1998) The FcγRIIIa-158F allele is a risk factor for systemic lupus erythematosus. Arthritis and Rheumatism, 41, 18131818.
  • Lard, L.R., Mul, F.P.J., de Haas, M., Roos, D. & Duits, A.J. (1999) Neutrophil activation in sickle cell disease. Journal of Leukocyte Biology, 66, 411415.
  • Malinowska, I., Obitko-Pludowska, A., Buescher, E.S., Wasik, M. & Rokicka-Milewska, R. (2001) Release of cytokines and soluble cytokine receptors after intravenous anti-D treatment in children with chronic thrombocytopenic purpura. Journal of Hematology, 2, 242249.
  • Newman, G.C., Novoa, M.V., Fodero, E.M., Lesser, M.L., Woloski, B.M.R. & Bussel, J.B. (2001) A dose of 75 mg/kg/d of IV anti-D increases the platelet count more rapidly and for a longer period of time than 50 mg/kg/d in adults with immune thrombocytopenic purpura. British Journal of Haematology, 112, 10761078.
  • Rochna, E. & Hughes-Jones, N.C. (1965) The use of purified 125I-labelled anti-g globulin in the determination of the number of D antigen sites on red cells of different phenotypes. Vox Sanguinis, 10, 675686.
  • Salama, A., Kiefel, V., Amberg, R. & Mueller-Eckhardt, C. (1984). Treatment of autoimmune thrombocytopenic purpura with rhesus antibodies [anti-Rh0(D)]. Blut, 49, 2935
  • Samuelsson, A., Towers, T.L. & Ravetch, J.V. (2001) Anti-inflammatory activity of IVIG mediated through the inhibitory Fc receptor. Science, 291, 484486.
  • Scaradavou, A., Woo, B., Woloski, B.M.R., Cunningham-Rundles, S., Ettinger, L., Aledort, L.M. & Bussel, J.B. (1997) Intravenous anti-D treatment of immune thrombocytopenic purpura: experience in 272 patients. Blood, 89, 26892700.
  • Semple, J., Allen, D., Rutherford, M., Woloski, M., David, M., Wakefield, C., Butchart, S., Freedman, J. & Blanchette, V. (2002) Anti-D (WinRho SD) treatment of children with chronic autoimmune thrombocytopenic purpura stimulates transient cytokine/chemokine production. American Journal of Hematology, 69, 225227.
  • Sewell, W.A., North, M.E., Cambronero, R., Webster, A.D. & Farrant, J. (1999) In vivo modulation of cytokine synthesis by intravenous immunoglobulin. Clinical and Experimental Immunology, 116, 509515.
  • Sharief, M.K., Igram, D.A., Swash, M. & Thompson, E.J. (1999) IV immunoglobulin reduces circulating proinflammatory cytokines in Guillain Barre Syndrome. Neurology, 52, 18331838.
  • Skull, S. & Kemp, A. (1996) Treatment of hypogammaglobulinaemia with intravenous immunoglobulin, 1973–93. Archives of Disease in Childhood, 74, 527530.
  • Smith, N.A. & Boughton, B. (1992) More on anti-D for the treatment of splenectomized patients with immune thrombocytopenic purpura. Blood, 79, 1891.
  • Teeling, J.L., Jansen-Hendriks, T., Kuijpers, T.W., de Haas, M., de Winkel, J.G., Hack, C.E. & Bleeker, W.K. (2001) Therapeutic efficacy of intravenous immunoglobulin preparations depends on the immunoglobulin G dimers: studies in experimental immune thrombocytopenia. Blood, 98, 10951099.
  • Tovo, P.A., Miniero, R., Fiandino, G., Saracco, P. & Messina, M. (1984) Fc-depleted vs. intact intravenous immunoglobulin in chronic ITP. Journal of Pediatrics, 105, 676677.
  • Wallace, P.K., Keler, T., Guyre, P.M. & Fanger, M.W. (1997) Fc gamma RI blockade and modulation for immunotherapy. Cancer Immunology Immunotherapy, 45, 137141.
  • Williams, W., Lynch, S., McCann, S. Smith, O., Feighery, C. & Whelan, A. (1998) Correlation of platelet FcγRIIA polymorphism in refractory idiopathic (immune) thrombocytopenic purpura. British Journal Haematology, 101, 779782.
  • van de Winkel, J.G.J. & Capel, P.J.A. (1993) Human IgG Fc receptor heterogeneity: molecular aspects clinical implications. Immunology Today, 14, 215221.
  • Wu, J., Edberg, J.C., Redecha, P.B., Bansal, V., Guyre, P.M., Coleman, K., Salmon, J.E. & Kimberly, R.P. (1997) A novel polymorphism of FcγRIIIa (CD16) alters receptor function and predisposes to autoimmune disease. Journal of Clinical Investigation, 100, 10591070.